Moderna logo

Moderna

Our mission is to deliver the greatest possible impact to people through mRNA medicines.

6245 employees · est. 2010 · Cambridge, United States

VS
Precigen logo

Precigen

Precigen (Nasdaq: PGEN) is a biopharmaceutical company advancing the next generation of gene and cell therapies.

152 employees · est. 2020 · Germantown, United States

Moderna is the older company (2010 vs 2020); Moderna is the larger of the two.

Side-by-Side Comparison

Moderna Precigen
Founded
2010 older 2020
Headquarters
Cambridge, United States Germantown, United States
Employees
6245 larger 152
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health and Wellness, Life Sciences
Funding Stage
Grant Post Ipo Equity
Total Funding
$3.91B $547.90M
Funding Rounds
15 7
Services
mRNA Medicine Development, Clinical Trials Execution, Biotechnology Research, Medical Affairs in Oncology, Drug Manufacturing and Testing Not tracked yet
Target Customers
Healthcare Professionals, Patients, Medical Researchers, Global Medical Institutions, Pharmaceutical Companies Not tracked yet
Taxonomy
MRNA Medicines, Vaccines Development, Therapeutics, Infectious Diseases, Cancer Treatment, Rare Diseases, Drug Modality, Genetic Disorders, Oncology, In Vivo Therapeutics, Strategic Partnerships, Protein Production, Antibody Production, Safety Monitoring Biopharmaceutical, Gene Therapy, Cell Therapy, Synthetic Biology, Precision Technology, Immuno-oncology, Autoimmune Disorders, Infectious Diseases, Clinical Stage, Innovation Engine, Discovery, Preclinical Pipeline, Commercialization, Synthetic Biology Solutions
Website
modernatx.com precigen.com
Moderna logo

About Moderna

Moderna, founded in 2010, has established itself as a trailblazer in the Biotechnology and Pharmaceutical industries, with a focus on developing mRNA medicines. The company's mission, "to deliver the greatest possible impact to people through mRNA medicines," highlights its dedication to transformin...

Precigen logo

About Precigen

Precigen, a biopharmaceutical company listed on Nasdaq (PGEN) is focused on advancing the next generation of gene and cell therapies. Founded in 1998 and headquartered in the United States, Precigen is dedicated to addressing urgent and intractable diseases in the areas of immuno-oncology, autoimmun...

We will tell you when either one moves

BounceWatch watches Moderna and Precigen for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Moderna and Precigen — by email.

Frequently Asked Questions

Moderna — Our mission is to deliver the greatest possible impact to people through mRNA medicines.. Precigen — Precigen (Nasdaq: PGEN) is a biopharmaceutical company advancing the next generation of gene and cell therapies.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Moderna has raised $3.91B while Precigen has raised $547.90M.
Moderna and Precigen operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Moderna with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Moderna on 15 Jun 2026, and Precigen on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy